EBV LMP2 Pep Pool 25ug/pep

Epstein-Barr Virus (EBV) Latent Membrane Protein 2 (LMP2) peptide pool from STEMCELL Technologies delivers a defined set of overlapping synthetic peptides spanning the LMP2 sequence, supplied at 25 ug per peptide for consistent antigen-specific T cell stimulation in immunology research.

This lyophilized pool is reconstituted in DMSO and applied to peripheral blood mononuclear cell cultures to map CD8+ and CD4+ responses against EBV-encoded antigens. Researchers employ the reagent in IFN-gamma ELISpot, intracellular cytokine staining, and multimer-based flow cytometry assays that probe latent EBV infection, transplant immunology, and vaccine development.

Intended for research use only, the peptide pool ships frozen on dry ice and should be stored at -80°C with single-use aliquots kept at -20°C to limit freeze-thaw cycles. Each vial supports multiple stimulations depending on the final working concentration, which is typically 1 to 2 ug/mL per peptide.

STEMCELL Technologies formats the product for compatibility with standard immunology workflows and high-throughput screening of donor samples. The pool is also valuable for validating TCR-engineered cell lines and benchmarking antigen presentation across EBV-positive B cell models.